The researchers found differences in mutational patterns among their African-American patients and that liquid biopsies seem to catch metastases early.
An international team of researchers also suggested that MUC16 mutations could identify patients who might benefit from immunotherapy treatment.
Wake Forest researchers are in the midst of an ongoing precision oncology trial to see how NGS-based tumor profiling and liquid biopsy assays can be implemented.
The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.
The researchers said the technique could be used to identify biomarkers specific to cancer or bacterial infection that are too small to detect by other methods.
This article was originally published May 23.
NEW YORK (GenomeWeb News) – Wake Forest University and spin-out company NanoMedica have received $860,000 in funding to move a bead-based genetic sequencing drug discovery technology closer to commercialization, Wake Forest said today.
Genome-wide association studies have put forward a vast number of SNPs associated with disease. Once you have those SNPs, the search is on for the causal variant.
Thermo Fisher Scientific, North Carolina Biotechnology Center, Life Technologies, Cenix BioScience, AstraZeneca, MultiCell Technologies, Maxim Biotech, CyBio, Axxam, PerkinElmer, Sangmyung University
JumpStart and Case Tech Ventures Invest in Neuros Medical; OGI Bets on UWO Spinout Cytognomix; Forma Collaborates with Singapore's ETC; and more …
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.
Slate's Jane Hu compares some at-home genetic tests to astrology.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.